Representing the Lekhim Group of Pharmaceutical Companies in a commercial dispute over the fulfilment of a vaccine supply agreement for almost UAH 1 Billion

Representing Lekhim Joint Stock Company, one of Ukraine's leading pharmaceutical companies engaged in the development, manufacture, and sale of medicinal products, in a commercial dispute with the Medical Procurement of Ukraine State Enterprise for almost UAH 1 billion.

The dispute between Lekhim and Medical Procurement of Ukraine arose from the fulfillment of a supply agreement for more than 1.9 million doses of the SARS-CoV-2 CoronaVac vaccine manufactured by Sinovac Biotech Ltd, a China-based biopharmaceutical company.

After reviewing the case, the commercial courts upheld the respondent’s (Lekhim’s) position by 97%, meaning that less than 3% of the claimed penalties were ordered to be paid.